Patent intelligence · US
US 11767330
Citrate salt, pharmaceutical compositions, and methods of making and using the same
Citrate salt, pharmaceutical compositions, and methods of making and using the same
Patent details — US 11767330
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 26, 2023
- Expiration
- Sep 21, 2043
- Applicant
- FOGHORN THERAPEUTICS INC.
- Claims
- 12
- CPC classes
- A61K, A61K31/4545
Quick answer
US 11767330 (Citrate salt, pharmaceutical compositions, and methods of making and using the same) is held by FOGHORN THERAPEUTICS INC.. Status: granted. Granted Sep 26, 2023. Expires Sep 21, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- FOGHORN THERAPEUTICS INC.
- Grant date
- Expiration
- Claims
- 12
- CPC classes
- A61K, A61K31/4545
More from FOGHORN THERAPEUTICS INC.
Related pharmaceutical patents in our USPTO index.
-
US 12391686
Compounds and uses thereof
granted -
US 12383555
Methods of treating cancers
granted -
US 12383560
Compounds and uses thereof
granted -
US 12384776
Compounds and uses thereof
granted -
US 12351579
Compounds and uses thereof
granted -
US 12139487
Compounds and uses thereof
granted -
US 11851445
Compounds and uses thereof
granted -
US 11787800
BRD9 degraders and uses thereof
granted
Frequently asked questions
What is US patent 11767330?
US 11767330 (Citrate salt, pharmaceutical compositions, and methods of making and using the same) is held by FOGHORN THERAPEUTICS INC.. Status: granted. Granted Sep 26, 2023. Expires Sep 21, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11767330?
FOGHORN THERAPEUTICS INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 14 pharmaceutical patents for this assignee.
When does US 11767330 expire?
Our index shows an expiration date of Sep 21, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.